Wednesday, 5 March 2014

Immune system-based therapy produces lasting remissions in melanoma patients, study reports

A drug that unleashes the immune system to attack cancer can produce lasting remissions and hold the disease in check – for more than two years, in some cases – in many patients with advanced melanoma, according to a new study by researchers at Dana-Farber Cancer Institute, Johns Hopkins University, Yale University, and allied institutions. Read more here.

No comments:

Post a Comment